Biomerica (BMRA) Share-based Compensation (2011 - 2026)

Biomerica has disclosed Share-based Compensation across 16 years of filings, most recently posting $58000.0 for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $58000.0, down 36.26% year-over-year; the trailing twelve-month figure through Feb 2026 was $371000.0 (down 29.6% YoY), and the FY2025 annual result was $460000.0, down 45.04% from the prior year.
• Share-based Compensation came in at $58000.0 for Q1 2026 at Biomerica, down from $72000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $384000.0 in Q1 2023 to a low of $58000.0 in Q1 2026.
• The 5-year median for Share-based Compensation is $170000.0 (2023), against an average of $196528.3.
• Across the five-year window, Share-based Compensation jumped 1212.59% in 2022 and sank 73.24% in 2025, its largest moves.
• Biomerica's Share-based Compensation stood at $318000.0 in 2022, then plunged by 61.64% to $122000.0 in 2023, then grew by 27.05% to $155000.0 in 2024, then sank by 53.55% to $72000.0 in 2025, then declined by 19.44% to $58000.0 in 2026.
• The last three Share-based Compensation figures came in at $58000.0 (Q1 2026), $72000.0 (Q4 2025), and $133000.0 (Q3 2025), per Business Quant data.